Fate Therapeutics (FATE) Share-based Compensation (2012 - 2026)
Fate Therapeutics (FATE) posted Share-based Compensation of $3.52 million for Q2 2026, down 50.8% from $7.15 million a year earlier and down 10.5% from the prior quarter.
Powered by 
Analysis
Fate Therapeutics (FATE) Share-based Compensation (2012 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Share-based Compensation at Fate Therapeutics was $17.84 million, down 49.6% year-over-year; for FY2025, it was $24.92 million, down 39.9% from FY2024.
- Annual Share-based Compensation has declined for three consecutive years, with a five-year compound annual growth rate of -4.1% (FY2020 to FY2025).
- In prior years, Fate Therapeutics' Share-based Compensation was $41.5 million in FY2024 (-4.5%), $43.46 million in FY2023 (-44.8%), $78.73 million in FY2022 (+44.8%) and $54.36 million in FY2021 (+76.8%).
- The Q2 2026 figure stands as the lowest quarterly Share-based Compensation since Q4 2018.
- On a year-over-year basis, Share-based Compensation has declined in each of the last seven quarters, with an average decline of 30.2% over the last eight quarters.
- The strongest year-over-year quarter for Share-based Compensation in the past five years was Q3 2021, with growth of 72.6%; the weakest was Q3 2025, with a decline of 58.7%.
- According to Business Quant data, Share-based Compensation for the three prior quarters was $3.93 million (Q1 2026), $5.53 million (Q4 2025) and $4.86 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 200.00 Mn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 357.00 Mn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 160.00 Mn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 369.00 Mn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | - |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 128.00 Mn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 234.00 Mn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 362.00 Mn |
| 10 | Fate Therapeutics | 215.18 Mn | 76.08 Mn | - | 2.70 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 2.70 Mn |
| Jun 30, 2026 | 3.52 Mn |
| Mar 31, 2026 | 3.93 Mn |
| Dec 31, 2025 | 5.53 Mn |
| Sep 30, 2025 | 4.86 Mn |
| Jun 30, 2025 | 7.15 Mn |
| Mar 31, 2025 | 7.38 Mn |
| Dec 31, 2024 | 9.12 Mn |
| Sep 30, 2024 | 11.77 Mn |
| Jun 30, 2024 | 9.63 Mn |
| Mar 31, 2024 | 10.98 Mn |
| Dec 31, 2023 | 9.48 Mn |
| Sep 30, 2023 | 10.10 Mn |
| Jun 30, 2023 | 12.90 Mn |
| Mar 31, 2023 | 10.98 Mn |
| Dec 31, 2022 | 19.39 Mn |
| Sep 30, 2022 | 19.47 Mn |
| Jun 30, 2022 | 20.54 Mn |
| Mar 31, 2022 | 19.33 Mn |
| Dec 31, 2021 | 14.59 Mn |
API Access
Fate Therapeutics Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=FATE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "FATE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=FATE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();